Burkly Linda 4
4 · Editas Medicine, Inc. · Filed Jul 25, 2023
Insider Transaction Report
Form 4
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Stock Option (right to buy)
2023-07-24+135,500→ 135,500 totalExercise: $8.66Exp: 2033-07-23→ Common Stock (135,500 underlying) - Award
Common Stock
2023-07-24+45,167→ 45,167 total
Footnotes (2)
- [F1]The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on July 24, 2024 continuing through July 24, 2027.
- [F2]This option was granted on July 24, 2023 and is scheduled to vest over four years, with 25% of the shares to vest on July 24, 2024 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 24, 2027.